YASHK is a vibrant community of young scientists dedicated to serving the community by enlightening future S&T talents.
YASHK is a vibrant community of young scientists dedicated to serving the community by enlightening future S&T talents.
Professor Xuechen LI has developed a new antibiotic called Kynomycin, which has obtained the Drug Clinical Trial Approval Notification from the National Medical Products Administration, allowing for clinical trials to be conducted.
Sign up to hear from us about updates and events.
Copyright © 2023 The Hong Kong Young Academy of Sciences - All Rights Reserved.
Powered by GoDaddy